NeuroPace (NPCE) EBITDA Margin (2020 - 2026)
NeuroPace (NPCE) posted quarterly EBITDA Margin of 25.23% for Q1 2026, down 238.0% year-over-year from 18.28% in Q1 2025, and down 279.65% quarter-over-quarter from 6.65% in Q4 2025.
NeuroPace (NPCE) EBITDA Margin (2020 - 2026) Analysis & Trends
NeuroPace's EBITDA Margin history runs 7 years deep, the most recent figure standing at 25.23% for Q1 2026.
- In Q1 2026, EBITDA Margin fell 238.0% year-over-year to 25.23%; the TTM figure through Mar 2026 stood at 16.84% (up 602.0% YoY), while the FY2025 annual figure was 16.34%, up 1078.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 25.23%, down from 6.65% in the prior quarter.
- The five-year high for EBITDA Margin was 6.65% in Q4 2025, with the low at 107.59% in Q2 2022.
- The 5-year median for EBITDA Margin is 32.35% (2024), against an average of 43.27%.
- The sharpest annual moves came in 2022 and 2023: EBITDA Margin tumbled 7113 bps in 2022, then jumped 6002 bps in 2023.
- NeuroPace's EBITDA Margin stood at 77.09% in 2022, then surged by 64 bps to 28.04% in 2023, then surged by 39 bps to 17.02% in 2024, then jumped by 61 bps to 6.65% in 2025, then tumbled by 280 bps to 25.23% in 2026.
- Business Quant data shows NPCE's EBITDA Margin at 25.23% in Q1 2026, 6.65% in Q4 2025, and 9.51% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 19.15% |
| 10 | NeuroPace | 468.25 Mn | 416.55 Mn | 18.91 Mn | -22.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -22.53% |
| Mar 31, 2026 | -25.23% |
| Dec 31, 2025 | -6.65% |
| Sep 30, 2025 | -9.51% |
| Jun 30, 2025 | -29.01% |
| Mar 31, 2025 | -22.85% |
| Dec 31, 2024 | -17.02% |
| Sep 30, 2024 | -20.15% |
| Jun 30, 2024 | -32.35% |
| Mar 31, 2024 | -41.63% |
| Dec 31, 2023 | -28.04% |
| Sep 30, 2023 | -36.22% |
| Jun 30, 2023 | -47.57% |
| Mar 31, 2023 | -57.48% |
| Dec 31, 2022 | -77.09% |
| Sep 30, 2022 | -91.41% |
| Jun 30, 2022 | -107.59% |
| Mar 31, 2022 | -85.83% |
| Dec 31, 2021 | -81.98% |
| Sep 30, 2021 | -60.38% |